Literature DB >> 7370051

Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.

R K Verbeeck, A Boel, A Buntinx, P J De Schepper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370051     DOI: 10.1016/0006-2952(80)90378-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  The effect of multiple dosage on the kinetics of glucuronidation and sulphation of diflunisal in man.

Authors:  R K Verbeeck; G R Loewen; J I MacDonald; R J Herman
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

2.  The influence of diflunisal on the pharmacokinetics of oxazepam.

Authors:  A M van Hecken; T B Tjandramaga; R Verbesselt; P J de Schepper
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

Review 3.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

4.  Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.

Authors:  J I Macdonald; S M Wallace; R J Herman; R K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Effect of cyclodextrins on protein binding of drugs: the diflunisal/hydroxypropyl-beta-cyclodextrin model case.

Authors:  E E Sideris; M A Koupparis; P E Macheras
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

6.  Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.

Authors:  G R Loewen; R J Herman; S G Ross; R K Verbeeck
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

8.  Human Serum Albumin (HSA) Suppresses the Effects of Glycerol Monolaurate (GML) on Human T Cell Activation and Function.

Authors:  Michael S Zhang; Jon C D Houtman
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.